Zobrazeno 1 - 4
of 4
pro vyhledávání: '"D Lamara"'
Publikováno v:
HemaSphere, Vol 6, Pp 1784-1785 (2022)
Externí odkaz:
https://doaj.org/article/33da71cc75154f25a89ce8d4756e1475
Autor:
L Belkesmaoui, F Smaili, K. Bouzid, F Grifi, L Touati, L Kara, I Bentahar, N Ait Ameur, M Oukal, S Oukid, H Harbadji, H Ait Ali, L Sahraoui, B Berber, R Sai, N Si Ali, M Belhani, Rose-Marie Hamladji, N Sidi Mansour, Naima Mesli, S Bougherira, A Djabellah, Y Ouarhlent, Mohamed Amine Bekadja, Malek Benakli, N Boudjerra, R Ahmed Nacer, S Bouaoud, M Saidi, M Allouda, F Belhadri, S Hamdi, N Lakhdari, T Filali, S Nekkal, Hadj Touhami, A Bachiri, M Bitam, D Lamara, L Louanchi, L Zatla, SE Belakehal, Z Zouaoui, N Mehalhal, S Bougoufa, Fz Ardjoun, L Charef, MT Abad, B Bendjabellah
Publikováno v:
Blood. 128:5403-5403
Introduction: Primitive extranodal lymphomas are a heterogeneous group of malignant lymphoid hematological developed from the mucosa-associated lymphoid tissue (MATL) or sites that have acquired MALT after repeated stimulation. The particularity of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74a9e92d62d412f046d606539938825a
https://doi.org/10.1182/blood.v128.22.5403.5403
https://doi.org/10.1182/blood.v128.22.5403.5403
Autor:
Rose-Marie Hamladji, M Belhani, Fz Brahimi, Farida Harieche, K Taibi, H Ghedira, A Maghraoui, A Trabzi, MT Abad, A Bouchakour, Y Meddour, N Boudjerra, Y Ben Youcef, Brahim Benzineb, S Gherras, M Saidi, Fz Touil, R. Ben Lakhal, M Attari, Fz Ardjoun, Z Zouaoui, Badra Enta-Soltane, T Ben Othman, Mohamed Amine Bekadja, Z Ouchenane, D Saber Cherif, A Graine, L Touati, HZ Manai, B Bendjabellah, Malek Benakli, C Kerrar, H Ait Ali, N Lakhdari, H Bellaaj, F Tibermacine, Mohamed Brahimi, N Mehalhal, Hadj Touhami, Ines Allam, S Hamdi, S Chaib, Samia Menif, A Bachiri, O Djidjik, S Taoussi, N Abdennebi, S Bougherira, B Meddeb, R Ahmed Nacer, N Sidi Mansour, Naima Mesli, K Djouadi, D Lamara, F Grifi, S Hadjeb, MA Laatiri, S Baghdad, F Kacha
Publikováno v:
Blood. 128:5440-5440
Introduction: Chronic myeloid leukemia (CML) accounts for 7%-15% of all leukemias affecting adults. The incidence in Algeria is 0.4/100,000 inhabitants in 2009. The aim of this study is to establish an Algerian-Tunisian epidemiological approach of CM
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c844803a99f9b8098c97e96fa3064d47
https://doi.org/10.1182/blood.v128.22.5440.5440
https://doi.org/10.1182/blood.v128.22.5440.5440
Autor:
Y Meddour, Malek Benakli, M Zenori, M Belhani, L Allam, N Abdennebi, K Djouadi, Z Brahimi, Z Ouchenane, Rose-Marie Hamladji, A Bouchakour, Brahim Benzineb, C Rahali, D Lamara, S Gherras, Fz Ardjoun, N Sidi Mansour, S Hamdi, N Boudjerra, Karima Taibi, Naima Mesli, Hadj Touhami, Mourad Nachi, A Bachiri, S Chaib, S Hadjeb, S Baghdad, N Mehalhal, Badra Enta-Soltane, S Bougherira, F Grifi, Z Zouaoui, Mohamed Amine Bekadja, R Ahmed Nacer, N Lakhdari, D Saber Cherif, C Kerrar, O Djidjik, B Bendjabellah, Mohamed Brahimi, Fz Touil, N Mansour, Farida Harieche, MT Abad, L Touati, H Ait Ali, A Graine, F Maghraoui, S Taoussi, M Benlazhar
Publikováno v:
Blood. 128:5454-5454
Introduction: The advent of anti-tyrosine kinase has revolutionized the treatment of chronic myeloid leukemia. Indeed, from 2000, the IMATINIB has become internationally the gold standard of treatment for CML chronic phase, while the allogeneic bone
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e23be95a17fe404e99d5ecceaeea7807
https://doi.org/10.1182/blood.v128.22.5454.5454
https://doi.org/10.1182/blood.v128.22.5454.5454